Skip to main content
OpenTrials

Clinical trial condition

Lung Diseases

Explore clinical trials studying Lung Diseases. Study availability and eligibility vary by location and protocol.

885 public trials 111 recruiting studies
Refine in advanced search Browse all conditions

Lung Diseases trial results

Completed

Efficacy and Safety of Longidaza® for the Treatment of Patients With Residual Changes in the Lungs After COVID-19

NCT06383819

Conditions
COVID-19, Chronic Disease, Coronaviridae Infections, +20 more
Locations
  • State Autonomous Healthcare Institution of the Sverdlovsk region "Aramil City Hospital" Aramil, Russia
  • Private healthcare institution "Clinical Hospital "RZD-Medicine" of the city of Chelyabinsk" Chelyabinsk, Russia
  • State Budgetary Healthcare Institution "Regional Clinical Hospital No. 3" Chelyabinsk, Russia
  • Alliance Biomedical-Ural Group LLC Izhevsk, Russia
View all 30 locations
View Trial Details
Completed

Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors

NCT03037385

Conditions
Adenocarcinoma, Adenocarcinoma, Papillary, Bronchial Diseases, +55 more
Locations
  • Mayo Clinic Hospital Phoenix, Arizona, United States
  • UC Irvine Medical Center Orange, California, United States
  • University of Colorado Anschutz Medical Campus Aurora, Colorado, United States
  • Georgetown University Medical Center Washington D.C., District of Columbia, United States
View all 71 locations
View Trial Details

Related conditions